These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 30738450

  • 21. Prognostic Value of Pre-Autologous Stem Cell Transplantation PET/CT in Diffuse Large B-Cell Lymphoma: The Deauville Score Is Prognostically Superior to ΔSUVmax.
    Zhang XY, Song L, Wang PJ, Wang L, Li Y, Wang YY, Shi CL.
    Acta Haematol; 2020; 143(2):124-130. PubMed ID: 31382264
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Interim 18F-FDG PET/CT and BCL2 for predicting the prognosis of patients with diffuse large B-cell lymphoma in the rituximab era.
    Jiang M, Chen P, Ruan X, Xu W, Li T, Wu L, Zhou W, Wu H, Wang Q.
    Nucl Med Commun; 2018 Feb; 39(2):147-153. PubMed ID: 29189488
    [Abstract] [Full Text] [Related]

  • 28. Midtreatment ¹⁸F-FDG PET/CT Scan for Early Response Assessment of SMILE Therapy in Natural Killer/T-Cell Lymphoma: A Prospective Study from a Single Center.
    Khong PL, Huang B, Lee EY, Chan WK, Kwong YL.
    J Nucl Med; 2014 Jun; 55(6):911-6. PubMed ID: 24819420
    [Abstract] [Full Text] [Related]

  • 29. Prognostic superiority of the National Comprehensive Cancer Network International Prognostic Index over pretreatment whole-body volumetric-metabolic FDG-PET/CT metrics in diffuse large B-cell lymphoma.
    Adams HJ, de Klerk JM, Fijnheer R, Heggelman BG, Dubois SV, Nievelstein RA, Kwee TC.
    Eur J Haematol; 2015 Jun; 94(6):532-9. PubMed ID: 25311082
    [Abstract] [Full Text] [Related]

  • 30. Interim [18F]fluorodeoxyglucose positron emission tomography scan in diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy plus rituximab.
    Safar V, Dupuis J, Itti E, Jardin F, Fruchart C, Bardet S, Véra P, Copie-Bergman C, Rahmouni A, Tilly H, Meignan M, Haioun C.
    J Clin Oncol; 2012 Jan 10; 30(2):184-90. PubMed ID: 22162590
    [Abstract] [Full Text] [Related]

  • 31. Prognostic value of interim 18F-FDG PET/CT in T-cell lymphomas.
    Qian L, Yan M, Zhang W, Zhou D, Zhang Y, Huo L, Luo Y, Zhang Y, Hu S.
    Leuk Lymphoma; 2020 Apr 10; 61(4):927-933. PubMed ID: 31795794
    [Abstract] [Full Text] [Related]

  • 32. [Prognostic value of pretreatment (18)F-FDG PET-CT for patients with advanced diffuse large B-cell lymphoma].
    Ding CY, Guo Z, Sun J, Yang WP, Li TR.
    Zhonghua Zhong Liu Za Zhi; 2018 Jul 23; 40(7):528-533. PubMed ID: 30060362
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Interim PET Evaluation in Diffuse Large B-Cell Lymphoma Using Published Recommendations: Comparison of the Deauville 5-Point Scale and the ΔSUVmax Method.
    Rekowski J, Hüttmann A, Schmitz C, Müller SP, Kurch L, Kotzerke J, Franzius C, Weckesser M, Bengel FM, Freesmeyer M, Hertel A, Krohn T, Holzinger J, Brink I, Haberkorn U, Nyuyki F, van Assema DME, Geworski L, Hasenclever D, Jöckel KH, Dührsen U.
    J Nucl Med; 2021 Jan 23; 62(1):37-42. PubMed ID: 32385164
    [Abstract] [Full Text] [Related]

  • 36. Improved prediction of chemoresistance in patients with diffuse large B-cell lymphoma through a new interim positron emission tomography-computed tomography evaluation model.
    Xie W, Liu MK, Jiang XF, Gao XD, Li B, Wang L, Zhao WL.
    Acta Oncol; 2021 Jun 23; 60(6):735-743. PubMed ID: 33720799
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. 18F-FDG PET/CT for Prognostic Stratification of Patients With Extranodal Natural Killer/T-Cell Lymphoma.
    Qin C, Yang S, Sun X, Xia X, Li C, Lan X.
    Clin Nucl Med; 2019 Mar 23; 44(3):201-208. PubMed ID: 30624268
    [Abstract] [Full Text] [Related]

  • 39. [Prognostic evaluation value of (18)F-FDG PET-CT in Hodgkin's lymphoma after treatment].
    Wan H, Liu P, Liang Y, Jiang SY, Lyu L, Zhang ZW, Wu N, Liu Y.
    Zhonghua Zhong Liu Za Zhi; 2021 Dec 23; 43(12):1275-1281. PubMed ID: 34915636
    [Abstract] [Full Text] [Related]

  • 40. [The Prognosis Assessment Value of Interim 18F-FDG PET/CT Imaging in the Chemotherapy of Diffuse Large B-cell Lymphoma].
    Peng XJ, Kou Y, Yu SS, Yao YT, Jiang XM, You JH, Zhang ZH, Chen SR, Jiang X, Cheng ZZ.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct 23; 30(5):1440-1445. PubMed ID: 36208247
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.